news Mechanisms behind synapse degeneration in Alzheimer’s unveiled 20 August 2021 | By Anna Begley (Drug Target Review) Researchers have uncovered a signalling pathway associated with glutamatergic synapse degeneration in the brains of mice with Alzheimer’s.
news Record-breaking 3D bioprinter could speed up drug development 16 August 2021 | By Anna Begley (Drug Target Review) Nanoengineers have developed a high-throughput bioprinter that 3D prints at record speed, potentially accelerating drug development.
news Targeting interferon kappa could control psoriasis inflammation 16 August 2021 | By Anna Begley (Drug Target Review) Scientists found that changing interferon kappa levels altered the severity of psoriasis inflammation and cytokine production in mice.
article Preventing stem cells from transforming into pre-leukaemia stem cells 1 February 2021 | By Victoria Rees (Drug Target Review) Researchers have discovered that two enzymes called APOBEC3C and ADAR1 work together to fuel the transition from pre-cancer stem cells to cancer stem cells in leukaemia.
news COVID-19 viral envelope simulation under development 25 March 2020 | By Hannah Balfour (Drug Target Review) Researchers are working to build a complete, all-atom model of the exterior of the coronavirus to aid in drug design.
news Using blue light to control CAR T cells and destroy tumours 21 February 2020 | By Victoria Rees (Drug Target Review) Researchers have created a method to activate CAR T cells with blue LED light to successfully combat solid tumours in mice.
